Skip to Content

W P97 (Primaquine Phosphate 26.3 mg (15 mg base))

Pill with imprint W P97 is Pink, Round and has been identified as Primaquine phosphate 26.3 mg (15 mg base). It is supplied by Sanofi-Aventis.

Primaquine is used in the treatment of malaria; pneumocystis pneumonia; malaria prevention and belongs to the drug class antimalarial quinolines. FDA has not classified the drug for risk during pregnancy. Primaquine 26.3 mg (15 mg base) is not a controlled substance under the Controlled Substances Act (CSA).

Images for W P97

Primaquine phosphate 26.3 mg (15 mg base) W P97
Primaquine phosphate 26.3 mg (15 mg base) W P97
Primaquine phosphate 26.3 mg (15 mg base) W P97

Primaquine phosphate

W P97
26.3 mg (15 mg base)
Prescription only
Drug Class:
Antimalarial quinolines
Pregnancy Category:
N - Not classified
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Inactive Ingredients:
carnauba wax
magnesium stearate
microcrystalline cellulose
polyethylene glycol 400
polysorbate 80
ferric oxide red
magnesium silicate
titanium dioxide
hypromellose 2910 (15000 mPa.s)
corn starch
Note: Inactive ingredients may vary.

Other Labelers / Repackagers:

NDC CodeLabeler / Repackager
43063-0225 PDRX Pharmaceuticals Inc. (repackager)

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2018, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.